NARA Discovery
Article Details
← Back to Search Results
Journal Article

The herbal extract EPs® 7630 increases the antimicrobial airway defense through monocyte-dependent induction of IL-22 in T cells

Katrin Witte; Egon Koch; Hans-Dieter Volk; Kerstin Wolk; Robert Sabat
Journal of Molecular Medicine · Vol. 98, Issue 10 · pp. 1493-1503 · 2020

Abstract

The phytotherapeutic compound EPs® 7630, an extract manufactured from Pelargonium sidoides roots, is frequently used for the treatment of airway infections. Nevertheless, the knowledge of the mode of action of EPs® 7630 is still sparse. Our study aimed at further elucidating the underlying pharmacological mechanisms by focusing on antimicrobial defense mechanisms of EPs® 7630. While investigating the influence of EPs® 7630 on lymphokine production by PBMCs, we found that EPs® 7630 is a novel inducer of IL-22 and IL-17. This cytokine-inducing effect was most pronounced for IL-22 and clearly dose-dependent starting from 1 μg/ml of the extract. Furthermore, EPs® 7630 pretreatment selectively enhanced the IL-22 and IL-17 production capacity of CD3/28-activated PBMCs while strongly limiting the IFN-γ production capacity of innate lymphoid cells. The relevance of EPs® 7630–induced IL-22 production was proven in vitro and in vivo , where IL-22 provoked a strong increase of the antimicrobial protein S100A9 in lung epithelial cells and pulmonary tissue, respectively. A detailed analysis of IL-22 induction modi revealed no direct influence of EPs® 7630 on the basal or anti-CD3/CD28 antibody-induced IL-22 production by CD4 + memory T cells. In fact, EPs® 7630–induced IL-22 production by CD4 + memory T cells was found to be essentially dependent on soluble mediators (IL-1/IL-23) as well as on direct cellular contact with monocytes. In summary, our study reveals a new immune-modulating function of EPs® 7630 that might confer IL-22 and IL-17-induced protection from bacterial airway infection. Key messages EPs® 7630 selectively strengthens IL-22 and IL-17 production of memory T cells. EPs® 7630 limits the IFN-y production capacity of innate lymphoid cells. EPs® 7630–caused IL-22 production by T cells is essentially dependent on monocytes. IL-22 increase antimicrobial proteins (AMPs) in airway epithelium. EPs® 7630 might protect against airway infection by induction of AMP-inducers.

Bibliographic Information

JournalJournal of Molecular Medicine
PublisherSpringer
Publication Date2020-10-01
Publication Year2020
Volume98
Issue10
Pages1493-1503
Document TypeJournal Article
Print ISSN0946-2716
eISSN1432-1440
DOI10.1007/s00109-020-01970-3

Access Information

NARA Access Coverage1922-01-01~Current
Journal Homepagehttps://www.springer.com/journal/109
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.